Latest News in the pharma Industry

Top Stories

Express Scripts Solution to Address Medication Non-adherence

Express Scripts Solution to Address Medication Non-adherence

18 Apr 2012

An innovative new solution could help to tackle the major problem of medication non-adherence.

Read more 
Takeda Announces URL Pharma Acquisition

Takeda Announces URL Pharma Acquisition

18 Apr 2012

Takeda is enhancing its gout treatment portfolio with the acquisition of URL Pharma.

Read more 
GE Healthcare Teams up with Clino to Accelerate Alzheimer's Research

GE Healthcare Teams up with Clino to Accelerate Alzheimer's Research

18 Apr 2012

GE Healthcare and Clino Ltd have announced a joint research project with a view to developing new diagnostic solutions for Alzheimer's disease.

Read more 
AMRI Announces Deal with Biota

AMRI Announces Deal with Biota

18 Apr 2012

AMRI’s role will initially involve the development and manufacture of the active pharmaceutical ingredient for use in clinical trials.

Read more 
Amgen to Acquire KAI Pharmaceuticals in $315M Deal

Amgen to Acquire KAI Pharmaceuticals in $315M Deal

17 Apr 2012

KAI Pharmaceuticals is to become a wholly owned subsidiary of Amgen.

Read more 
Humira Receives EU Approval for Ulcerative Colitis

Humira Receives EU Approval for Ulcerative Colitis

16 Apr 2012

Abbot's biologic therapy Humira has now received EU approval for the treatment of adult patients with ulcerative colitis.

Read more 
Shire Announces Top-line Results of Prevent2 Phase-III Trial of MMX Mesalamine

Shire Announces Top-line Results of Prevent2 Phase-III Trial of MMX Mesalamine

5 Apr 2012

Shire has revealed that it does not plan to pursue a regulatory filing for MMX mesalamine in patients with a history of diverticulitis, after the drug failed to meet the primary endpoint in a recent phase-III study.

Read more 
Merck Announces Publication of Phase-III Data for Shingles Vaccine Zostavax

Merck Announces Publication of Phase-III Data for Shingles Vaccine Zostavax

5 Apr 2012

Efficacy and safety data that supported the US FDA's expanded indication for Zostavax in 2011 have been published in Clinical Infectious Diseases.

Read more 
Catalent & BASF Form Bioavailability Alliance

Catalent & BASF Form Bioavailability Alliance

5 Apr 2012

The companies will combine their expertise to provide a range of services to address pipeline challenges with BCS Class II and IV poorly bioavailable compounds.

Read more 
Lonza Names New CEO

Lonza Names New CEO

5 Apr 2012

Richard Ridinger has been named chief executive officer of Lonza and will take over the role on May 1.

Read more 
Charles River & Metabolon Ink Biomarker Pact

Charles River & Metabolon Ink Biomarker Pact

5 Apr 2012

The cooperation combines Charles River’s preclinical oncology study expertise with Metabolon’s analysis of metabolic data to identify both mechanism of action and biomarkers.

Read more 
AKESOgen & London Genetics International Form Alliance

AKESOgen & London Genetics International Form Alliance

30 Mar 2012

The two firms will collaborate to help biopharma companies take advantage of pharmacogenetic solutions, including novel biomarker and assay development services.

Read more